ARS Pharmaceuticals, Inc.
SPRY•NASDAQ•Healthcare•Biotechnology

About ARS Pharmaceuticals

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.

Company Information

SectorHealthcare
IndustryBiotechnology
CEORichard Lowenthal
Founded2015
Employees160
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitears-pharma.com
Phone858 771 9307
Address
11682 El Camino Real, Suite 120 San Diego, California 92130 United States

Corporate Identifiers

CIK0001671858
CUSIP82835W108
ISINUS82835W1080
EIN81-1489190
SIC2834

Leadership Team & Key Executives

Richard E. Lowenthal M.B.A., M.S., MSMSEL
Co-Founder, President, Chief Executive Officer and Director
Dr. Sarina Tanimoto M.B.A., M.D.
Co-Founder and Chief Medical Officer
Brian T. Dorsey M.S.
Chief Operating Officer
Dr. Robert Bell Ph.D.
Co-Founder and Chief Science Officer
Kathleen D. Scott CPA
Chief Financial Officer
Alexander A. Fitzpatrick Esq.
Chief Legal Officer and Secretary
Daniel Relovsky
Senior Vice President of Marketing
Lynda Harris
Vice President of Human Resources
Justin Chakma
Chief Business Officer
Harris Kaplan M.B.A.
Executive Vice President of Commercial Strategy